ASH, in collaboration with The Henry Loring Masters Foundation, is pleased to announce a new webinar on the topic of autoimmune hemolytic anemia (AIHA). AIHA is an acquired disease that occurs when antibodies form against a person's own red blood cells. One of the most important issues associated with the early diagnosis and acute management of AIHA is the communication between the blood banker and the hematologist. Diagnosis followed by acute and chronic management of AIHA involves the use of appropriate diagnostics to suspect, confirm and manage the treatment patients with AIHA.
Presentation and Speakers:
Moderator: Samuel M. Silver, MD, PhD
Univeristy of Michigan Medical School
Marc Kahn, MD, MBA
Tulane University School of Medicine, New Orleans, Louisiana
Dr. Kahn will discuss the symptoms associated with AIHA, the differential diagnosis in this group of patients and the laboratory tests used to confirm diagnosis. In addition, Dr. Kahn will present information regarding the acute and long term management of AIHA patients.
Leslie E. Silberstein, MD
Boston Children's Hospital, Boston, Massachusetts
Dr. Silberstein will present information related to the important role of the blood bank in making the diagnosis, how and when blood transfusions are an acceptable treatment for patients with AIHA, including challenges in finding the best matched blood cells for transfusion. He will also discuss the important roles of the blood banker and hematologist in managing the quality of care for these patients.
ASH is grateful to The Henry Loring Masters Foundation for building awareness among caregivers, patients, and families of the critical path and timelines for treatment of Autoimmune Hemolytic Anemia (AIHA) in young people and for providing support for the development and distribution of this valuable webinar.